Meeting the challenges of PET-based molecular imaging in cancer.

about

Nuclear imaging: a powerful novel approach for tuberculosis.

P2860

Q34315731-727C8920-D031-4237-BEB1-B662902E4FC8

P2860

Meeting the challenges of PET-based molecular imaging in cancer.

Item

http://www.wikidata.org/entity/Q39345390

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Meeting the challenges of PET-based molecular imaging in cancer.

@en

Meeting the challenges of PET-based molecular imaging in cancer.

@nl

type

Item

label

Meeting the challenges of PET-based molecular imaging in cancer.

@en

Meeting the challenges of PET-based molecular imaging in cancer.

@nl

prefLabel

Meeting the challenges of PET-based molecular imaging in cancer.

@en

Meeting the challenges of PET-based molecular imaging in cancer.

@nl

P1476

Meeting the challenges of PET-based molecular imaging in cancer.

@en

P2093

Esther Mena

http://www.w3.org/2001/XMLSchema#string

Maria L Lindenberg

http://www.w3.org/2001/XMLSchema#string

Peter Choyke

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.

Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.

Translational molecular imaging for cancer.

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.

P304

671-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737159.2013.835568

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karen A. Kurdziel

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24063395

http://www.w3.org/2001/XMLSchema#string

Meeting the challenges of PET-based molecular imaging in cancer.

about

P2860

P2860

Meeting the challenges of PET-based molecular imaging in cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698